FDA News: Issue 1-3, January 2022

Author: [AUTHOR] Published on 1/14/2022 5:00:00 AM

FDA Announces Upcoming Principles of Pediatric Clinical Pharmacology Lecture Series

The 2021-2022 Principles of Pediatric Clinical Pharmacology lecture series offered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) resumed on January 5, 2022. Two upcoming US Food and Drug Administration (FDA) roundtable discussions will be presented as a part of this series:
  • February 16, 2022: FDA Roundtable Discussion on Systems Pharmacology
  • April 6, 2022: FDA Roundtable Discussion on Pharmacometrics and Clinical Trials Design

This lecture series is designed to address the fundamentals of clinical pharmacology from a pediatric perspective. 1.00 AMA PRA Category 1 Credits™ are available for each lecture.

Registration is free and open to the public. Lectures are given via live webinar in Adobe Connect on Wednesdays from 12:00 PM to 1:00 PM ET. Login details are emailed to course registrants before each webinar. You are welcome to attend these and all other webinars in the course, as well as to share the links below with any interested trainees or colleagues.

To register, visit https://cvent.me/Vng9ve

To view the course schedule, visit https://cvent.me/OmbxdR

For additional information, please contact pharmcourse@infinityconferences.com

The Office of Clinical Pharmacology (OCP) is pleased to offer the e-mail subscription service Clinical Pharmacology Corner. This is a free service from FDA to provide occasional updates from OCP regarding newly approved therapies, new regulatory and scholarly publications, upcoming events and other items of interest. Subscribe today at https://updates.fda.gov/subscriptionmanagement (note: this link does not work with Internet Explorer) and select Clinical Pharmacology Corner under Drugs.

We always welcome your thoughts regarding the format, content, and utility of this communication. Comments may be sent via email to ocp@fda.hhs.gov.

This communication was prepared by Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA.

Sort by:
Photo Gallery
Recent News
Contact Us